Salmonella enterica serovar agona for anti-tumor therapy
The present invention provides Salmonella enterica serovar Agona and/or knockdown strain of Salmonella enterica serovar Agona, optionally genetically engineered, for use in anti-tumor therapy.
Main Authors: | , , |
---|---|
Format: | Patent |
Published: |
2013
|
Summary: | The present invention provides Salmonella enterica serovar Agona and/or knockdown strain of Salmonella enterica serovar Agona, optionally genetically engineered, for use in anti-tumor therapy. |
---|